A Food and Drug Administration panel will meet Monday to discuss a class of drugs designed to treat chronic painful conditions that currently are under development and the safety issues possibly related to the drugs.
The National Association of Chain Drug Stores on Friday applauded the Senate for passage of the Counterfeit Drug Penalty Enhancement Act (S. 1886), which NACDS said would protect the health and safety of consumers by increasing penalties on criminals that engage in the harmful practice of trafficking in counterfeit medications.
Written testimony submitted by the National Association of Chain Drug Stores underscored chain pharmacies’ commitment to patient safety as part of the next Prescription Drug User Fee Act reauthorization, and emphasized that community pharmacist-provided services help improve health outcomes without the introduction of unproven technologies.
Walgreens last week outlined how the company's research has demonstrated the ability of face-to-face pharmacy and Take Care Clinic programs to drive better health outcomes at the IMS Managed Markets Services/Data Niche Conference held here.
The Centers for Disease Control and Prevention on Friday issued its latest update on the influenza season to date, or rather the lack thereof. For the week ended Feb. 25, visits for influenza-like illnesses have yet to crack the national baseline of 2.4% this season.
Two bills designed to protect "covered critical infrastructure" against cyber attacks by terrorists and others should remain focused on their key purpose and not be expanded to include data breach legislation or broad new privacy regimes, the National Retail Federation said.